September 1998
Volume 39, Issue 10
Free
Articles  |   September 1998
Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition.
Author Affiliations
  • P Hardy
    Department of Pediatrics, Research Center of Hôpital Sainte-Justine, Montreal, Quebec, Canada.
  • M Bhattacharya
    Department of Pediatrics, Research Center of Hôpital Sainte-Justine, Montreal, Quebec, Canada.
  • D Abran
    Department of Pediatrics, Research Center of Hôpital Sainte-Justine, Montreal, Quebec, Canada.
  • K G Peri
    Department of Pediatrics, Research Center of Hôpital Sainte-Justine, Montreal, Quebec, Canada.
  • P Asselin
    Department of Pediatrics, Research Center of Hôpital Sainte-Justine, Montreal, Quebec, Canada.
  • D R Varma
    Department of Pediatrics, Research Center of Hôpital Sainte-Justine, Montreal, Quebec, Canada.
  • S Chemtob
    Department of Pediatrics, Research Center of Hôpital Sainte-Justine, Montreal, Quebec, Canada.
  • M Bhatthacharya
    Department of Pediatrics, Research Center of Hôpital Sainte-Justine, Montreal, Quebec, Canada.
Investigative Ophthalmology & Visual Science September 1998, Vol.39, 1888-1898. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P Hardy, M Bhattacharya, D Abran, K G Peri, P Asselin, D R Varma, S Chemtob, M Bhatthacharya; Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition.. Invest. Ophthalmol. Vis. Sci. 1998;39(10):1888-1898.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

PURPOSE: To determine the relative contribution of cyclooxygenase (COX)-1 and COX-2 in regulating prostaglandin (PG) E2 and PGF2alpha receptors (EP and FP, respectively) densities and their functions in retinal vasculature of neonatal pigs. METHODS: Newborn pigs were treated intravenously every 8 hours for 48 hours with saline, 40 mg/kg nonselective COX inhibitor ibuprofen, 80 mg/kg COX-1 inhibitor valeryl salicylate, or 5 mg/kg DuP697 and 5 mg/kg NS398, COX-2 inhibitors. Retinal microvessel EP and FP receptor densities were measured by radioligand binding and receptor-coupled effects by determining second-messenger inositol 1,4,5-trisphosphate (IP3) and vasomotor responses. Retinal blood flow (RBF) response to incremental increases in blood pressure (BP) was measured by a microsphere technique. RESULTS: Valeryl salicylate, DuP697, and NS398 reduced retinal PGE2 and PGF2alpha concentrations in the newborn by approximately half, whereas ibuprofen caused further reduction to levels observed in adults. Retinal vessel EP1, EP3, and FP receptor densities increased approximately threefold after treatments with COX-1 or COX-2 inhibitors, and five- to sixfold after ibuprofen treatment. EP and FP receptor upregulation was associated with corresponding increases in IP3 production and retinal vasoconstriction in response to PGF2alpha, fenprostalene (an FP agonist), PGE2, 17-phenyl trinor PGE2 (an EP1 agonist), and M&B28,767 (an EP3 agonist) and with enhanced RBF autoregulation of high BP (> or =125 mm Hg). Conversely, EP2 receptor density and coupled functions were minimally affected by COX inhibition. CONCLUSIONS: Data suggest that increased COX-1- and COX-2-catalyzed prostaglandin synthesis contribute equivalently to the downregulation of retinovascular EP1, EP3, and FP receptors and their vasoconstrictor functions in newborn pigs; the EP2 receptor was not significantly influenced by ontogenic alterations in prostaglandin levels.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×